Bausch Health
BHC
#4228
Rank
A$3.86 B
Marketcap
A$10.41
Share price
-0.14%
Change (1 day)
-13.34%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): A$1.48

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is A$1.46. In 2024 the company made an earnings per share (EPS) of A-$0.18 an increase over its 2023 EPS that were of A-$2.44.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$1.48-918.33%
2024A-$0.18-92.59%
2023A-$2.44160.89%
2022A-$0.94-76.64%
2021A-$4.0168.45%
2020A-$2.38-68.91%
2019A-$7.65-57.11%
2018A-$17.83-272.22%
2017A$10.35-199.29%
2016A-$10.43798.7%
2015A-$1.16-128.31%
2014A$4.10-204.62%
2013A-$3.92602.7%
2012A-$0.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.43-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
A-$0.36-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA